Valuation: Hikal Limited

Market Cap 26.66B 282M 251M 234M 212M 400M 407M 2.81B 1.1B 13.91B 1.06B 1.03B 44.52B P/E 2027 *
72.1x
P/E 2028 * 24x
Enterprise Value 26.66B 282M 251M 234M 212M 400M 407M 2.81B 1.1B 13.91B 1.06B 1.03B 44.52B EV / Sales 2027 *
1.43x
EV / Sales 2028 * 1.25x
Free-Float
30.9%
Yield 2027 *
-
Yield 2028 * -
1 day-1.01%
1 week-3.89%
Current month-0.65%
1 month-3.77%
3 months-8.75%
6 months+18.46%
Current year-4.57%
1 week 208.21
Extreme 208.21
219.3
1 month 203.83
Extreme 203.83
240.88
Current year 146.25
Extreme 146.25
257
1 year 146.25
Extreme 146.25
261
3 years 146.25
Extreme 146.25
464.75
5 years 146.25
Extreme 146.25
595
10 years 56.9
Extreme 56.9
742
Manager TitleAgeSince
Chief Executive Officer 52 01/01/1996
Director of Finance/CFO - 05/11/2020
Chief Tech/Sci/R&D Officer - 26/12/2024
Director TitleAgeSince
Chairman 78 16/05/2012
Chairman 52 01/10/2026
Director/Board Member 51 22/07/2010
Change 5-day change 1-year change 3-year change Capi.($)
-1.01%-3.89% - - 283M
+4.86%+8.99%+54.22%+106.73% 1,077B
+0.84%+0.01%+34.17%+62.82% 612B
+2.17%+5.95%+27.59%+96.04% 501B
+1.36%+5.10%+77.91%+43.69% 364B
+2.37%+7.66%+33.65%+50.58% 353B
+2.64%+6.95%+21.01%+44.38% 278B
+3.24%+6.78%+0.43%+15.73% 251B
+3.26%+8.38%+48.52%+53.92% 230B
+3.61%+8.31%+34.67%+101.16% 190B
Average +2.26%+1.97%+36.91%+63.90% 428.5B
Weighted average by Cap. +2.82%+1.58%+40.73%+73.45%

Financials

2027 *2028 *
Net sales 18.64B 197M 176M 163M 149M 279M 284M 1.96B 767M 9.73B 739M 723M 31.12B 21.28B 225M 201M 186M 170M 319M 325M 2.24B 876M 11.1B 843M 825M 35.53B
Net income 374M 3.95M 3.52M 3.28M 2.98M 5.61M 5.71M 39.35M 15.4M 195M 14.82M 14.5M 624M 1.11B 11.74M 10.48M 9.74M 8.86M 16.67M 16.97M 117M 45.78M 580M 44.06M 43.13M 1.86B
Net Debt - -
Projected Income Statement - Annual - Hikal Limited
Logo Hikal Limited
Hikal Limited is an India-based company, which is engaged in the manufacturing of various chemical intermediates, specialty chemicals, active pharma ingredients and contract research activities. The Pharmaceuticals segment produces active pharmaceutical ingredients. Its facilities are in Jigani, Bangalore and Panoli, Gujrat. The Crop protection segment produces pesticides and herbicides. Its facilities are in Taloja, Mahad, Maharashtra and Panoli, Gujarat. Its human health product categories include anti-convulsant, anti-emetic, anti-histaminic, anti-depressant, anti-psychotic, anti-lipemic, and hemorheologic. Its animal health product categories include anti-tick, anti-parasitic, analgesic, anabolic steroids, female sex hormone, and NSAID. Its crop protection products are used in algaecide, biocide, fungicide, herbicide, insecticide, and intermediate. It offers contract research services for synthesis, process development, and manufacturing projects.
Employees
2,152
Date Price Change Volume
15/10/26 ₹216.47 -1.01% 133,282
14/10/26 ₹218.68 +2.61% 267,708
13/10/26 ₹213.12 +0.14% 252,891
12/10/26 ₹212.83 -0.39% 375,406
09/10/26 ₹213.66 +0.68% 293,602
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
216.25INR
Average target price
300.00INR
Spread / Average Target
+38.73%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Hikal Limited